This is the last episode of the Biotech Series, and this final episode delves into the emerging field of immuno-oncology in Dubai and the GCC, discussing the development of personalized cancer treatments that activate the immune system to fight cancer, tailored to individuals' genetic makeup.

It outlines the ambitious goals of creating immuno-oncology drugs specifically for the region, addressing the most common cancers, including breast, lung, and colorectal cancer.

The discussion covers drug development challenges, including obtaining funding, integrating with existing healthcare systems, and leveraging AI and government initiatives to speed up the process.

The script highlights the potential of T cell receptor targeted therapeutics and the role of artificial intelligence in drug discovery. Interviews with industry experts emphasize the importance of personalized medicine and the vision of making Dubai a global hub for cutting-edge cancer treatment research and development.

00:00 Introduction to Immuno Oncology in Dubai 00:55 The Battle Against Cancer: Targets and Challenges 02:09 The Journey of Drug Development and Personalized Medicine 02:55 Navigating the Early Stages of Immuno Oncology Projects 04:25 Building a Global Hub for Cancer Research and Treatment 11:57 The Future of TCR Technology and Its Impact on Oncology 18:43 Exploring the Potential of Predictive Oncology and Screening 22:11 Addressing the Challenge of Cancer Treatment Affordability 23:57 Exploring the Costs and Challenges of Cancer Therapy 24:33 The Role of AI in Revolutionizing Cancer Treatment 26:32 Navigating the Complexities of Drug Costs and Healthcare Systems 28:36 The Intricacies of Drug Patents and Their Impact on Innovation 33:40 Personal Journeys: From Clinical Practice to Biotech Innovation 47:12 The Future of Cancer Care: Bringing Cutting-Edge Treatments to Dubai